Sera Prognostics, Inc. (SERA) Documents: SEC Filings, Investor Presentations & Press Releases

Sera Prognostics, Inc. (SERA) documents, SEC filings and the IR site together: 94 documents, newest first; latest 2026-08-19. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-08-198-KForm 8-K, Item 5.02
2026-08-128-KForm 8-K, Item 2.02 results
2026-08-1210-QForm 10-Q for the quarter ended Jun 30
2026-07-09Press releasePRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDE
2026-06-30Press releaseSERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS
2026-06-308-KForm 8-K, Item 5.02
2026-06-24Press releaseSERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH
2026-06-23Press releaseSERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY
2026-06-048-KForm 8-K, Item 5.07
2026-06-01Press releaseSERA PROGNOSTICS ANNOUNCES BOARD TRANSITION
2026-06-018-KForm 8-K, Item 5.02
2026-05-20Deck2026 Corporate Presentation
2026-05-06Press releaseSERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
2026-05-068-KForm 8-K, Item 2.02 results
2026-05-0610-QForm 10-Q for the quarter ended Mar 31
2026-04-24ProxyDefinitive proxy statement
2026-03-18Press releaseSERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
2026-03-188-KForm 8-K, Item 2.02 results
2026-03-1810-KAnnual report on Form 10-K, FY25
2026-02-17Press releaseSERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE
2026-01-088-KForm 8-K, Item 7.01
2026-01-07Press releaseLandmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications
2026-01-078-KForm 8-K, Item 7.01
2025-11-248-KForm 8-K, Item 7.01
2025-11-13Press releaseSERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
2025-11-138-KForm 8-K, Item 2.02 results
2025-11-1310-QForm 10-Q for the quarter ended Sep 30
2025-09-058-KForm 8-K, Item 7.01
2025-08-068-KForm 8-K, Item 2.02 results
2025-08-0610-QForm 10-Q for the quarter ended Jun 30
2025-06-058-KForm 8-K, Item 5.07
2025-05-088-KForm 8-K, Item 7.01
2025-05-078-KForm 8-K, Item 2.02 results
2025-05-0710-QForm 10-Q for the quarter ended Mar 31
2025-04-23ProxyDefinitive proxy statement
2025-03-198-KForm 8-K, Item 2.02 results
2025-03-1910-KAnnual report on Form 10-K, FY24
2025-02-128-KForm 8-K, Item 1.01
2025-02-108-KForm 8-K, Item 8.01
2025-01-318-KForm 8-K, Item 2.02 results

SERA overview · SERA earnings · SERA financials · SERA KPIs · SERA ownership · SERA peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.